people die every year from drug-resistant infections. Without urgent action, this number is projected to increase exponentially. By investing in research and development for new treatments, for everyone who needs them, we can save lives.
dollars are lost annually due to hospital-acquired infections in the US and Europe. Drug resistance is making these infections harder to treat. In turn, surgical procedures and cancer treatment carry greater risk. New antibiotics are needed to protect our healthcare systems.
The discovery of antibiotics transformed our world by making previously incurable illnesses treatable and allowing medical procedures like operations and chemotherapy to be performed safely. Millions of lives have been saved and our well-being radically improved. But our time with these drugs is running out. Antibiotics have been used so extensively many infections are once more untreatable.
Drug-resistant bacteria can infect anyone, of any age, in any country. It’s why antibiotic resistance is one of the biggest threats to global health. We can’t afford to wait.
We need to fund the research and development of new antibiotics today. And ensure access to these treatments for everyone who needs them, wherever they live.
Millions of people worldwide contract infections from harmful bacteria and are increasingly dying due to the lack of effective antibiotics. Your donation will support the research and development of urgently needed antibiotics, and access to these treatments for all who need them.
Health is a powerful driver of productivity, social stability and economic growth. Everyone’s health is dependent on effective antibiotics. Investing in the research and development of new treatments is good value for money that helps build a more prosperous future.
Drug-resistant bacterial infections can infect anyone, of any age, in any country. But it is our most vulnerable who are hit first and hardest. You can support the research and development of antibiotics to protect those most at risk: newborns, people with weakened immune systems, those in hospitals requiring medical procedures, and the elderly.
“We are running out of antibiotics that work. We haven’t invested in finding new ones, while the old ones are failing more by the day. Antibiotics are a precious resource. They save so many lives and we need to develop more of them.”
Vanessa Carter is an international patient advocate for Antimicrobial Resistance (AMR). She has used her personal experience of AMR to help change the lives of others. Vanessa tells her compelling story to GARDP.
Vanessa Carter, AMR Patient Advocate
Learn why there is a drug resistance crisis, why so few new antibiotics have been developed and how you can support GARDP in our mission to ensure everyone who needs antibiotics receives effective treatments, no matter where they live.Download DOCUMENT now